Newsroom

Sorted by: Latest

-

OPM Biosciences führt eine integrierte Plattform von Zellkulturmedien bis zur Herstellung für die Entwicklung von Biosimilars ein

PLEASANTON, Kalifornien--(BUSINESS WIRE)--OPM Biosciences, ein Anbieter von Zellkulturmedien und Bioprozesslösungen, gab heute zwei neue Angebote bekannt, mit denen die OPM-CHO™-Plattform auf die Entwicklung und Herstellung von Biosimilars ausgeweitet wird: den „Biosimilar Media Optimization Service“ und die „Sureness™ Biosimilar Platform“. Zellkulturmedien können das Zellwachstum, die Produktivität und kritische Qualitätsmerkmale (CQAs) erheblich beeinflussen, wodurch die Medienstrategie zu ei...
-

Samenvatting: OPM Biosciences lanceert geïntegreerd platform gericht op celkweekmedia en grootschalige productie voor de ontwikkeling van biosimilars

PLEASANTON, Calif.--(BUSINESS WIRE)--OPM Biosciences, een bedrijf gespecialiseerd in celkweekmedia en oplossingen voor bioprocessen, kondigde vandaag twee nieuwe aanbiedingen aan die zijn OPM-CHO™-platform naar ontwikkeling en productie van biosimilars uitbreiden: de Biosimilar Media Optimization Service en het Sureness™ Biosimilar Platform. Celkweekmedia kunnen celgroei, productiviteit en CQA's (critical quality attributes) aanzienlijk beïnvloeden, waardoor mediastrategie een belangrijke compo...
-

Faraday Future Announces This Week’s Investor Weekly Report From YT Jia Has Been Rescheduled to September 28; FF EAI “Built in USA” Upstream & Downstream Business Partner Conference Part Two to Be Held September 29

LOS ANGELES, Calif.--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (“EAI”) ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia, originally scheduled for September 27, has been rescheduled for September 28, one day later than planned. Additionally, the Company has invited 10 global partners to participate in its FF EAI “Built in...
-

Mitsubishi Electric to Support Relief Efforts Near Nepal–China Border Following Flooding and Debris Flows

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the Mitsubishi Electric Group will donate a total of 5 million yen (approximately US$ 32,000) to aid victims of flooding and debris flows that occurred near the Nepal–China border in August. The Mitsubishi Electric Group expresses its deepest sympathies to all those affected by the disaster and extends its very sincerest wishes for a speedy recovery. The Group will continue its efforts to support those af...
-

Flashlight Capital Calls on Samsung to Put S-1 Stake Up for Open Auction

SINGAPORE--(BUSINESS WIRE)--Flashlight Capital Partners Pte. Ltd. ("Flashlight Capital") today called on the five Samsung Group affiliates that together hold 20.6% of S-1 Corporation (KRX: 012750) ("S-1") – Samsung SDI, Samsung Life Insurance, Samsung Fire & Marine Insurance, Samsung Card and Samsung Securities – to sell their stake through an open auction. On August 27 (KST), Flashlight Capital offered to acquire the affiliates' entire holding of 7,815,656 shares at KRW116,000 per share, o...
-

Wolfspeed Expands 200 mm Silicon Carbide Portfolio with New Premium Power Substrates

DURHAM, N.C.--(BUSINESS WIRE)--Wolfspeed, Inc. (NYSE: WOLF), a global leader in silicon carbide (SiC) technology, today announced the commercial availability of its new Premium 200 mm n-type silicon carbide substrate, expanding its 200 mm SiC materials portfolio with a higher-quality starting material designed to improve yield through reduced defects and greater wafer-shape stability. As the SiC devices industry pushes toward higher voltages and larger die sizes, material-level quality and wafe...
-

Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic HDV on September 28, 2026...
-

Pampers & 4Kira4Moms Host Los Angeles Community Baby Shower Supporting 30 Deserving Parents

CINCINNATI--(BUSINESS WIRE)--Pampers and 4Kira4Moms hosted a Los Angeles baby shower, connecting 30 expecting families with maternal health resources and diapers....
-

War Heroes on Water Presented by loanDepot Underway as 130 Combat-wounded Veterans Fish Southern California Waters

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--130 combat-wounded veterans embarked on a meaningful journey as they set out from Newport Harbor for the ninth annual War Heroes on Water (WHOW)....
-

Sun Nuclear Announces Validated Adaptive QA Solution in Support of New Radiotherapy System, Accela, by Siemens Healthineers

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, today announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technical experts and clinical partners for interoperability with the company's new radiotherapy system, Accela. Unveiled at the annual ASTRO conference, Accela is the first software-driven delivery system engineered for NeoArc (Dynamic Modulated Arc Therapy, DMAT), a new treatment technique that accelerates how radia...